6/14/2024  2:25:13 PM Chg. +4.4000 Volume Bid5:35:23 PM Ask9:58:41 PM Market Capitalization Dividend Y. P/E Ratio
245.4000EUR +1.83% 58
Turnover: 14,056.3000
-Bid Size: - -Ask Size: - 15.01 bill.EUR 0.30% 82.17

Business description

The Sartorius Group is a leading international pharmaceutical and laboratory equipment provider with two divisions: Bioprocess Solutions and Lab Products & Services. Bioprocess Solutions with its broad product portfolio focusing on single-use solutions helps customers produce biotech medications and vaccines safely and efficiently. Lab Products & Services, with its premium laboratory instruments, consumables and services, concentrates on serving the needs of laboratories performing research and quality assurance at pharma and biopharma companies and on those of academic research institutes.
 

Management board & Supervisory board

CEO
Joachim Kreuzburg
Management board
Rainer Lehmann, Dr. René Fáber, Gerry MacKay, Alexandra Gatzemeyer
Supervisory board
Dr. Lothar Kappich, Manfred Zaffke, Prof. David Raymond Ebsworth, Dr. Daniela Favoccia, Petra Kirchhoff, Dietmar Müller, Ilke Hildegard Panzer, Frank Riemensperger, Hermann Jens Ritzau, Prof. Dr. Klaus Rüdiger Trützschler, Sabrina Wirth
 

Company data

Name: Sartorius AG
Address: Otto-Brenner-Str. 20,D-37079 Goettingen
Phone: +49-551-308-0
Fax: +49-551-308-3289
E-mail: info@sartorius.com
Internet: www.sartorius.de
Industry: Technology
Sector: Other Technology Industries
Sub sector: -
End of financial year: 12/31
Free Float: 40.81%
IPO date: 7/10/1990

Investor relations

Name: Petra Kirchhoff
IR phone: +49-551-308-1686
IR Fax: -
IR e-mail: petra.kirchhoff@sartorius.com

Company calendar

CW 29 | 7/19/2024 Interim Report 2nd Quarter/6 Months
CW 42 | 10/17/2024 Interim Report 3rd Quarter/9 Months
 

Main Shareholders

Freefloat
 
72.00%
Bio-Rad Laboratories
 
28.00%